Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs United Parcel Service Inc (UPS) Price & Performance

Abeona Therapeutics IncTrade
United Parcel Service IncTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs United Parcel Service Inc — how do they compare? Abeona Therapeutics Inc trades at $7.42 (market cap $424.33M), while United Parcel Service Inc trades at $104.44 (market cap $89.09B). The key difference: United Parcel Service Inc is far larger — about 210× Abeona Therapeutics Inc's market cap, and United Parcel Service Inc pays a 6.26% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.

ABEOUPS
Market Cap
$424.33M$89.09B
Sector
HealthIndustrials
52-Week High
$7.45$120.00
52-Week Low
$4.17$82.58
Enterprise Value
$279.23M$113.11B
Volume
2,288,643
Dividend Yield
6.26%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Abeona Therapeutics Inc

ABEO trades at $7.24, up 4.93% today, with bullish technical signals from moving averages. The company shows exceptional profitability with 454.86% net income margin and 70.99% ROE, though revenue remains modest at $5.82M. Recent developments include CMS granting NTAP status for ZEVASKYN and expansion to seven treatment centers, while Q2 2026 earnings are scheduled for August 13, 2026.

Strong analyst support (66.7% buy ratings) and attractive valuation metrics (P/E 7.84, EV/EBITDA 3.8) support upside potential, but negative operating cash flow and shareholder investigation pose near-term risks. The stock's outlook depends on commercial execution and Q2 earnings results.

United Parcel Service Inc

UPS trades at $104.48, up 1.24% daily, with a bearish technical signal but recent earnings beats. Revenue declined to $88.66B in 2025, with net income margin at 5.08%, while valuation ratios like P/E of 19.42 and P/S of 0.99 suggest moderate pricing. The company maintains a strong dividend yield, with recent payouts of $1.64 per share, and analyst consensus is mixed amid cost-cutting efforts and Amazon volume reset.

Outlook is cautious due to margin pressures and competitive threats, but upside exists if operational efficiencies materialize. Risks include high debt-to-asset ratio of 33.02% and volatile cash flows. Analysts target $117.90 on average, implying potential growth, but investor sentiment remains divided given bearish technical trends.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About United Parcel Service Inc

United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network

Read more on UPS